In a recent manuscript from Abot et al., E4 has been shown to be able to activate in vivo the ER alpha-dependent signaling that mediate protection from atherosclerosis development, while failing to activate the membrane-initiated signaling involved in ER alpha-dependent re-endothelialization and eNOS activation (51). The gene discussed is ESR1; the disease is atherosclerosis.